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ABSTRACT 
  
This research was carried out to study the current situations of 
contagious bovine pleuropneumonia (CBPP) in Khartoum State by 
isolation and serological technique.  
Fifty-five pneumonic lung tissue samples, out of 750 lungs 
examined in slaughterhouses in the State were collected. Six pneumonic 
lung tissue samples were also collected from animals showing typical 
signs and post-mortem lesions of CBPP in Alkadaro, Khartoum North. 
Two hundred serum samples were collected randomly from animals in 
different areas of the State and screened for antibodies against 
Mycoplasma mycoides subsp. mycoides (small colony type) using 
competitive ELISA test. Two Mycoplasmas were isolated from infected 
cases in Alkadro. The isolates were recovered from pneumonic lungs 
showing typical post-mortem lesions of the disease which included 
fibrinonecrotic pneumonia with yellowish fluid and sequestra. The two 
isolates were identified as Mycoplasma mycoides subsp. mycoides by 
their cellular morphology, cultural characteristics and growth inhibition 
tests. One hundred and fourteen, out of the 200 randomly collected serum 
samples, were seropositive for CBPP with competitive ELISA test. 
The isolation and identification of the causative agents and 
serosurvaillence findings of this study confirmed high prevalence (57%) 
of CBPP in Khartoum State.  
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INTRODUCTION 
 
Contagious bovine pleuropneumonia (CBPP) is a severe disease 
affecting cattle as well as buffaloes. It creates great economic losses in 
endemic regions and is declared by the Office International des Epizootic 
(OIE) to be disease of list A. 
Mycoplasmas are the smallest free living microorganisms found so 
far. The mycoplasmas are widely distributed and many of them are 
pathogenic to humans, animals and plants (Dienes, 1994). The range of 
animal hosts varies from nonhuman primates to domestic animals. 
Animals mycoplasmas are essentially extracellular parasites with special 
affinity to mucous membranes in respiratory system, the urogenital tract, 
the mammary glands or serous membranes. Many mycoplasmas are non-
pathogenic (commensals), while others are pathogenic to a widely 
varying degree. The pathogenic mycoplasmas are largely host specific, 
but closely related animals species may share the same mycoplasmas 
flora. The most common types of animal diseases caused by 
mycoplasmas are pneumonia, arthritis and mastitis.  
The most important animal mycoplasmas belong to Mycoplasma 
mycoides cluster. Two members of Mycoplasma mycoides cluster         
are of particular importance, Mycoplasma mycoides subsp mycoides small 
colony type (MmmSC) causing contagious bovine pleuropneumonia 
(CBPP) and Mycoplasma capricolum subsp. capripneumoniae (Mccp) 
causing the contagious caprine pleuropneumonia (CCPP).  
CBPP was eradicated from most continents during the 19th century 
but remained endemic in Africa. In Sudan CBPP remains to be persistent 
constrain of animal production. The disease is endemic in many parts of 
the country. It causes serious economic losses in the form of exhaustion 
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of the affected animal and finally death. Moreover, it affects adversely 
the country livestock trade and export to foreign markets and especially 
to traditional markets in the Middle East.  
The current research was carried out to study the situation of CBPP 
in Khartoum State. This was fulfilled by:  
1. Detection of CBPP in slaughterhouses and suspected areas by 
isolation and identification of the causative agents.  
2. Serological screening of animals in the state for antibodies against 
Mmm (SC) using competitive enzyme linked immunosorbent 
assay.  
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CHAPTER ONE 
LITERATURE REVIEW 
    
1.1 History and distribution of disease 
 There is no full solid information about the time and place 
where contagious bovine pleuropneumonia (CBPP) was reported for 
the first time in the world. According to Carrason (1942), the disease 
was first observed in Italy and France in the middle of the sixteenth 
century. The development of the international trade in middle of the 
nineteenth century helped greatly the spread of the disease to England 
and Scandinavian countries. By 1803, the disease was reported in the 
United State of America (Jasper, 1967). The disease was introduced in 
South Africa in 1854 from Britain (Hutgra et al., 1971). In 1958 the 
disease was carried by sea to Australia through infected cattle (Turner, 
1954).  
 Due to strict control measurement at the end of the nineteenth 
century and at the beginning of the twentieth century, the disease was 
eradicated from the USA, 1852 and most of the European countries 
e.g. England, 1898 and Russia 1940 (Jasper, 1967).       
 It was reported as late as 1958 in Portugal (Ferronha et al., 
1990), further outbreaks occurred in 1961 in Spain and then in the 
Department des Pyrenee-Oruntales in France in 1967 (Anon, 1967, 
1980, 1982 and 1984, Provost et al., 1987) where some mortality was 
recorded in three herds (Turner, 1961).  
 Infection in Portugal was reported to be widespread in 1983 
with serological evidence suggesting that the disease had been present 
for months, may be years before (Ayling et al., 1999). CBPP was 
endemic in northwestern parts of Portugal around Porto, but outbreaks 
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subsequently decreased significantly. Spain began reporting cases of 
CBPP from 1989. Whilst the first cases occurred around Madrid and 
Segovia, the majority of outbreaks were in the northern coastal areas 
broadening the Bay of Biscay (Turner, 1961).  
 In 1990 Italy reported its first outbreak for over 100 years in 
Piedmont in the north. The disease quickly spread to most major cattle 
areas of Italy. However, as a result of abattoir surveillance, movement 
control linked to serological monitoring, and slaughter of infected and 
in contact animals, no cases have been reported since September 1993. 
For the first time for over 20 years, no outbreaks were reported in 
Europe in a year 2000. 
 The sources of outbreaks of CBPP in Italy (1990-1993) was 
never successfully traced, although France was heavily implicated by 
virtue of the large number of cattle exported to Italy from there and 
because they had experienced the disease in the previous decade, 
immunological evidence was presented by Poumarate and Solsona 
(1995) that most strains from Italy were different from those of 
outbreaks in Western Europe leading to the suggestion that 
"contamination of Italy did not arise from exportation of CBPP from 
Southwestern Europe" but from a resurgence in Italy itself or from 
some unknown foci elsewhere in Europe.  
 Outbreak of CBPP usually begins as the result of movement of 
an infected animal into a naive herd. It is widely believed that 
recovered animals which harbor the causative agent within pulmonary 
sequestra might become active shedder when stressed (Windson and 
Masiga, 1977).  
The disease is still present in most African countries south of 
the Sahara, India and China (Hudson, 1971). Recently, there are 
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reports on severe outbreaks of CBPP in Kenya, Uganda, Ethiopia, 
South Africa, Asia and North Portugal (OIE, 2001).  
In the Sudan the disease was first observed in 1875 in Darfur 
Province and later spread to Khartoum Province where it caused great 
losses among cattle (Anon, 1952). The disease disappeared during the 
Mahdi wars in 1889 and it reappeared again in Kordofan Province in 
1912.  
From there the disease spread quickly southward and eastwards 
of the province. In 1913 the disease was reported in Nuba Mountains, 
the White Nile, Upper Nile and Bahr El Gazal Provinces. In 1914 the 
disease reached Khartoum Province and then spread to Berber 
Province in 1913 and Kassala Province in 1917 (Anon, 1925).  
The Pan African control of Epizootics (PACE) in 2003 showed 
that the disease is currently endemic in most parts of the Sudan 
especially in areas below 15oN latitude with varying degree of severity 
and with highest prevalence incidence in the south Equatoria States 
(Bahr Al Gabel State and Kaboita in east Equatoria), Upper Nile 
States (Renk, Fashoda, Elnasir, Malakal. Akopo and in Goungali 
State), Bahr Al Gazal State (Wau, Raja, Nahr Al Gor, Awil, and 
Rumbek) and Warab Lakes States.  
The disease is frequently reported from eastern states near 
Ethiopian border in Doka and Al Galabat in Gedarif State.  
Al Managel (Gezira State), Al Dinder and Singa (Sinnar State), 
Al Rossires and Al Angasana (Blue Nile State) and Algabalin and 
Kosti (White Nile State) are the endemic areas in the Central States.  
Southern Kordofan State is also endemic area and reports were 
received from Al Delling, Kadogli and Abu Gebiha in the Southern 
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Kordofan State up Babanosa, Almoglad and Abeyei in the southern 
part of the Western Kordofan State. CBPP is widely spread in 
Southern Darfur State specially areas of El Dain, Buram and Radom.  
Sporadic cases were reported in Khartoum State (Mageed, 
2003). The disease was not reported in the northern Sudan (River Nile 
and Northern and Red Sea States) for more than 15 year.  
1.2 Taxonomy 
The mollicutes represent a class of unique cell wall-less 
prokaryotes that include members of the genus mycoplasma.  
        According to International Committee on Systemic Bacteriology-
Subcommitte on the Taxonomy of Mollicutes, the class contain the 
following orders, families and genera  
Order I  :   Mycoplasmatales 
Family I :  Mycoplasmataceae  
Genus II:  Mycoplasma  
Order II :  Entomoplasmatales  
Family I :  Entomoplasmataceae  
Genus I :  Entomoplasma  
Genus II:  Mesoplasma  
Family II:  Spiroplasmataceae  
Genus I :  Spiroplasma  
Order III:  Acholeplasmatales  
Family I :  Acholeplasmataceae  
Genus I :  Acholeplasma  
Order IV:  Anaeroplasmatales  
Family I :  Anaeroplasmataceae  
Genus I :  Anaeroplasma 
Genus II:  Asteroplasma  
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The members of this class are eubacteria that are bound by a 
single membrane. The major class characteristics are the lack of cell 
wall, the tendency to form fried-egg type colonies on solid media, the 
filterability of cells through 450 and 220 nm pore-size membrane 
filters, the presence of A-T-rich genome, and the failure of the wall-
less to revert to walled bacteria under appropriate conditions.  
Taxonomy within orders and families is based on sterol 
requirement, cell and colony morphology, optimum growth 
temperature and requirement for oxygen. Differences at genera and 
species levels are based on the above mentioned parameters beside the 
host origin, genome size and cultural and biochemical properties. 
More than 102 Mycoplasma species have been discovered. The most 
important animal pathogens belong to Mycoplasma myciodes cluster 
(Freundt and Edward, 1979).  
1.3 Aetiology  
 CBPP is caused by Mycoplasma mycoides subsp. mycoides 
(Mmm SC) (Nocard et al., 1898). The causative agent (Mmm SC) is a 
member of the mycoplasma mycoides cluster which include 6 
biochemically and antigenically similar mycoplasmas of animal 
importance (Table 1) (Haraswa, 2000). Species and subspecies within 
this cluster are difficult to distinguish by morphological and 
conventional biochemical tests. Although Mmm SC was considered to 
be host specific but it has been isolated from pneumonic lungs of 
sheep and goats (Brando, 1995; Thiaucoart et al., 1999). This may 
constitute a difficulty in the control of the disease in areas where 
cattle, sheep and goats are raised together. 
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Table 1: Mycoplasma mycoides cluster 
Mycoplasma Type strain Principal animal host Disease 
Other animal 
host 
M. mycoides 
subsp. mycoides 
type 
PG1 Cattle CBPP Buffaloes goats, sheep 
M. mycoides 
subsp. capri  PG3 Goats 
Pleuropneumonia 
arthritis  
M. mycoides 
subsp mycoides 
LC  
Y-goat Goats Pleuropneumonia Sheep, cattle 
M. capricolum 
subsp 
capripneumoniae  
F38 Goats CCPP Sheep 
M. capricolum 
subsp capricolum   California Kid Goats Mastitis, arthritis Sheep, cattle 
Mycoplasma sp. 
Bovine group 7 
(leach)   
PG50 Cattle Arthritis Goats, sheep 
 
Zaki (2001). 
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Mycoplasma mycoides subsp. mycoides was classified into 
small colony type (SC) and large colony type (LC) according to their 
morphology, cultural and biochemical characteristics (Cottew and 
Yeast, 1978). The large colony type activity digests casein, liquefies 
serum and survives at 45oC. These together with differences in growth 
characteristics and others permitted differentiation of the two types.  
1.4 Host range 
 Contagious bovine pleuropneumonia is predominantly a disease 
of the Bovidae of the kind Bos (Bos. taurus and Bos indicus). There is 
a variation in susceptibility to infection; in general European breads 
tend to be more susceptible than indigenous African breeds (Provost  
et al., 1987). Animal less than 3 years of age are less resistant to 
experimental challenge (Masiga et al., 1978). The susceptibility of 
cattle to infection with M. mycoides depends on many factors such as 
the type of animal husbandry, individual resistance and other factors 
(Shallali, 1997).  
In 2002 the infection was recorded in bison and yak. Although 
it has been reported that the domestic buffalo (Bubalus bubalis) is 
susceptible, the disease is difficult to reproduce experimentally in this 
species (Provost, 1988).  
1.5 Transmission of the disease 
Spread of the disease from infected to susceptible animals is 
mainly through inhalation of infected droplets which may be carried to 
10-20 meters or more by the air currents (Turner, 1954). Factors, 
which influence the infection rate, are closeness of contact, intensity 
of infection and the level of individual susceptibility (Turner, 1954).  
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Even under extensive condition the gathering of animals at 
watering places will lead to outbreaks and will maintain the disease in 
herds (Coetzer et al., 1994).  
The disease may not be detected for several weeks or months 
after infected animals have entered an area. Some animals also have a 
degree of resistance to the disease and those surviving CBPP are even 
more resistant (Coetzer et al., 1994). Outbreaks usually begin as a 
result of movement of an infected animal into a naive herd. It is 
widely believed that recovered animals harboring infectious 
organisms within pulmonary sequestra may become active when 
stressed. Although this may be a factor in some outbreaks, it has not 
been proved experimentally (Windsor, 1977).  
Asymptomatically and chronically infected animals are very 
important in the spread of the disease to new areas. Chronic carriers 
are apparently healthy animal that have a localized focus of infection 
sequestered in a fibrous capsule in their lungs. The organisms can 
persist in such lesion for months, and in time the fibrous capsule may 
breakdown, allow viable organisms to escape by the bronchi and so 
infect susceptible in contact animals. This is particularly proved to 
occur when chronic carrier animals are subjected to stress such as 
when mustered or walked for long distances.  
Mycoplasma can pass through the placenta from the infected 
dams to the off-spring (Stone, 1969).  
1.6 Symptoms of the disease 
The incubation period of the natural disease may range from 5 
to 207 days. Although Turner and Campbeel (1937) reported a range 
of 29-58 days and Provost et al. (1987) stated 20 to 40 days. In 
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experimental infection, Regalla et al. (1994) reported that the disease 
symptoms appear in cattle 40 days after contact with inoculated 
animals and these symptoms lasted for 20 days.  
The disease may be either clinical or sub-clinical. The clinical 
form may be acute, sub-acute or chronic (Turner, 1954).  
The clinical signs in a typical acute case include a rise in body 
temperature (up to 40oC), shallow and rapid respiration in the early 
stage of the disease, which soon becomes abdominal with painful 
granting. The neck is extended. There is an excess mucous in the 
nostrils and frothy saliva around the mouth and occasionally soft 
cough is heard (Bygrave   et al., 1968; Hudson, 1971).  
In sub-acute cases lesions are localized in small part of the lung, 
the position of which cannot be easily located by percussion and 
auscultation. The only symptom is a rare cough, sometimes new foci 
of infection are created and acute symptoms set in (Henning, 1965).  
In chronic cases the only symptom is a cough that usually 
appears when the animal rises or when it suddenly passes from a 
warm stable to cold weather or when it drinks cold water (Henning, 
1965).  
Sub-clinical and chronic cases of CBPP constitute more than 
50% of animals involved in an epizootic (Bygrave et al., 1968). In 
calves about one year old or less the clinical picture of the disease in 
primarily characterized by arthritis and the chest may be free from any 
lesion (Moulton et al., 1956; Turner and Trethewic, 1961; Simmons 
and Johnson, 1963; Harbi and Salih 1979 and Elmahi, 1980).  
1.7 Pathology and post-mortem findings 
Pathological lesions are confined to the thoracic cavity. 
Different degree of pathological changes may be found in an animal. 
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Lesions are usually unilateral without a preference for the left or right 
side. The lesion is always localized in the diaphragmatic lobe. The 
cranial lobe seldom affected in the acute stage. Many liters of serous 
fluid are usually present in the thoracic cavity. The fluid is clear 
yellow-brown and may contain pieces of fibrin. A thick caseous 
fibrinous deposit is frequently present on the visceral and parietal 
pleura which is a pathognomnic sign. Another pathognomonic sign of 
CBBP is that the interlobular septa are distended by amber-coloured 
serous fluid which gives the lung the marbling appearance. The 
hepatized lung lobules have different colours varying from relatively 
normal to deep red or yellow-gray due to acute fibrinonecrotic 
pneumonia (OIE, 2001). 
In the chronic stage, an adhesion connects the thickened 
visceral and parietal pleura. When the thoracic cavity is opened pieces 
of lung adhere to chest wall. The fluid in the thoracic cavity may 
disappear. The lung parenchyma appears oedematous with red 
consolidation. The interlobular septa are distended with lymph fluid 
(Turner, 1959; Hudson, 1971 and Liyloid, 1970). A necrotic portion or 
portions of the lung are walled off by a fibrinous tissue capsule 
forming what is known as sequestrum (Turner, 1959 and Liyloid, 
1970). Sequestra vary in size from a centimeter in diameter to 20-30 
cm in their greatest diameter (Hudson, 1971).  
Nevertheless, the classical picture of the disease showing 
marbling appearance, consolidation, adhesion of the pleura and 
considerable amount of pleural fluid was reported in naturally infected 
calves (El Tahir et al., 1988). 
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1.8 Diagnosis 
1.8.1 Clinical diagnosis   
 Tentative diagnosis depends on clinical signs, PM findings and 
demonstration of Mmm (SC) in pleural fluid of infected animal by 
dark field microscopy. But other confirmatory tests are necessary. The 
methods of diagnosis have advantages and disadvantages (Table 2). 
1.8.2 Differential diagnosis 
In carrying out CBPP clinical diagnosis, some sources of 
confusion may occur. Therefore, it is very important to differentiate 
this disease from other diseases which may have similar clinical signs 
or lesions. 
1.8.3 Histopathology 
Early in the course of the disease, the CBPP lesion comprise a 
bronchiolar necrosis and oedema which progress rapidly to an 
exudative serofibrinous bronchiolitis with extension to the alveoli and 
uptake of alveolar fluid into tissue spaces, lymph vessels and 
ultimately septal lymphatics (Done et al., 1995). These rapidly reach 
saturation and the process is extended centrifugally to the 
tracheobronchial lymph nodes and centripetally to the pleural 
lymphatics. The mediastinal, sternal, aortic and intercostal lymph 
nodes may then become enlarged, oedematous or even haemorrhagic. 
With stasis, lymph vessels become thrombosed and ultimately 
fibrosed (Buttery et al., 1980). The pulmonary lobules become 
consolidated with alveolar oedema, fibrin and inflammatory cells. 
Coagulative necorsis is common. Mmm SC can be demonstrated in 
these lobules by immonohistochemistry.  
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Table (2): The advantages and disadvantages of the methods of diagnosis. 
Method of diagnosis Some advantages Some disadvantages Sample types Preservation and storage 
Isolation and identification diagnosis very sure Slow and requires viable pathogenic agents Lungs, pleural, liquid  
Under cold in order to 
guarantee the viability of 
the pathogenic agent 
Serology (detection of the 
antibodies) Speed and simplicity 
Some tests are not very 
sensitive and for the 
majority do not allow to 
differentiate the post 
infectious antibodies from 
the vaccine antibodies 
Blood in a tube without 
anticoagulant (to harvest 
serum) 
Under cold to avoid the 
degradation of the 
antibodies 
Molecular biology 
Speed, sensibility and 
effective even when the 
pathogenic agent is not 
viable any more in the 
sample 
Expensive and requires a 
suitably equipped 
laboratory and adequately 
trained personnel 
Pleural, liquid, lungs, nasal 
swabs 
Does not require any 
particular precaution 
Histopathology 
Simplicity and does not 
require the conservation of 
the samples under cold 
temperature 
Presumptive diagnosis, 
requires some heavy 
equipment and adequately 
trained personnel 
Tissues (lungs) In 10% of neutral formal saline 
 
Razin and Tully (1981) 
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 Perivascular organization foci or 'organizing centers', found in 
the interlobular septa, are considered pathognomonic for CBPP 
(Ferronha    et al., 1988). They consist of a center occupied by a blood 
vessel with proliferation of connective and inflammatory cells. Two 
types of foci have been recognized (Numes Petisca et al., 1988). Type 
I foci contains more proliferative cells in the central zone which is 
larger than the peripheral zone and probably corresponds to the 
success of the host immune response in resolving the infection; 
immunoreactive antigen is associated with macrophages. In type II 
foci, the proliferative cells are scarce and the peripheral zone is 
relatively larger. Immunoreactive antigen can be seen in the central 
zone inside blood vessels and it is thought that Type II foci indicate 
failure of the immune response leading to aggravation of symptoms.  
In an immunocytochemical study of CBPP infected Italian 
cattle, Scanziani et al. (1997) showed that the severity of lung lesions 
correlated with the severity of changes in the lymph nodes. In the 
acute stage of the disease specific antigen was detected in the lobular 
periphery and in the cytoplasm of alveolar macrophages. In chronic 
lesions, immunoreactivity was in the fibrotic areas and in 
macrophages located in the lobular septa; necrotic debris and 
macrophages located in the inner part of the sequestra were 
specifically stained. Immunoreactive material was also seen in the 
centrofollicular areas of the broncho-associated lymphoid tissue 
structures and in the lymph node follicles. Furthermore, electron 
microscopy of the mediastinal lymph nodes of a chronically affected 
calf showed degenerating mycoplasmas and a few apparently intact 
mycoplasmas in the macrophages.  
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The histological section of the lung in acute stage of the disease 
showed odema in the lymphatics of the interlobular septa and 
interstitial tissue and massive infiltration of fibrin, macrophage and 
neutrophils into the alveolar lumen (Bygrave et al., 1968). Also there 
was presence of lymphocytes and alveolar macrophages around the 
lymphatic vessels and septa margin (Jubb and Kennedy, 1963). In 
chronic cases the main lesions are the sequestra and fibrinous scars 
(Jubb and Kennedy, 1963; Bygrave     et al., 1968).  
1.8.4 Isolation of the organism 
 If the animal died, pleural fluid or affected lung can be 
collected aseptically for cultural examination in selective media 
(Gourlay, 1973). Sterile paper can be soaked with pleural fluid or 
allowed to absorb fluid from lung lesion (Turner, 1954).  
When the animal died, pleural fluid or affected lung can be 
collected aseptically for cultural examination in a selective medium. 
The organism can be cultivated in different liquid or solid media 
depending on the availability of facilities in each laboratory. Different 
media are available for the isolation and cultivation of Mmm SC. 
Basically they are composed of two parts; the basic medium and the 
supplement. The basic part is a broth of lean meat heart muscle or 
liver (Bennett, 1932; Campbell, 1938; Dafalla, 1961; Gourlay, 1962; 
El Nasri, 1972 and Buttley, 1967). The supplement consists of equine 
or swine serum, yeast extract, DNA, glucose and also penicillin and 
thallium acetate as bacterial and fungal inhibitors.  
Nowadays many basic commercial media as PPLO and brucella 
media are available for isolation and propagation of mycoplasma.  
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Growth of this organism in liquid medium culture becomes 
apparent as uniform faint turbidity within 3-6 days after aerobic 
incubation at 37oC. The organism is described as pleomorphic 
occurring as round ovoid, ring and filamentous forms in liquid media 
(Edward, 1950 and Turner, 1954). Colonies on solid media grow 
slowly in 3-6 days and are different in diameter and difficult to be 
seen by naked eye.   
1.8.5 Biochemical tests  
a) Glucose fermentation 
 Some strains of mycoplasma ferment glucose and produce acid 
(Erno and Stipkovits, 1973).  
b) Hydrolysis of ariginine: 
 Some strains of mycoplasma, hydrolize arginine and shift the 
medium to alkaline (Erno and Stipkovits, 1973). This is done by the 
action of arginine deaminase as a character associated with non-
fermentative and some of the fermentative mycoplasma.  
c) Phosphotase activity: 
 It was done by incorporating phenolphthalein diphosphate in 
agar media as described by Eron and Stripkovits (1973). The activity 
is manifested by change of the colour of media to pink.  
 Film and spots phenomenon was first described by Edward 
(1950) and Edward and Fizgerald, (1954). This test is of diagnostic 
value and is used to indicate the lipolytic activity of certain 
mycoplasmas containing the enzyme lipase. Characteristic, wrinkled, 
pearly film with tiny black spots appear on the surface of the medium 
that contains horse serum or egg yolk. The film consist of cholesterol 
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and phospholipids and the spots contain calcium and magnesium salts 
of fatty acids.  
e) Serum digestion: 
  The method was described by Eron and Stripkovits (1973). The 
proteolytic activity is determined by the ability of the organism to 
digest coagulated serum.  
f) Terazolium reduction: 
 This was usually done in liquid media (Erno and stripkovits, 
1973) but others use solid media (Senterfit, 1973). It shows the ability 
of some mycoplasma to reduce 2, 3, 5 Triphenyl tetrazolium chloride 
to brick red formozan. The ability of the strains to reduce tetrazolium 
was noticed to be higher under anaerobic than aerobic conditions.  
g) Haemolysis:  
 The test is performed on agar or in broth culture, both showing 
various degree of haemolyosis due to the production of peroxide by 
the organism.  
h) Hemadsorption: 
 The observation of the adsorption of erythrocytes to 
mycoplasma colonies is detected microscopically. This property is 
used to measure the ability of mycoplasma to adhere to eukaryatic 
cells, hence it is related to the pathogenicity of the organism (Shmuel 
and Tully, 1983).   
1.8.6 Serology 
 Two groups of serological tests are used. Specific identification 
of isolated mycoplasma relies heavily of growth inhibition test (GIT) 
and immunofluorescence (IF). 
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Serological diagnosis of CBPP depends on antibody detection 
using different tests e.g. CFT, ELISA, Agglutination tests… etc.  
1.8.6.1 Complement fixation test (CFT) 
 Complement fixation test is currently the official and the most 
widely used serological diagnostic test. It is thought to be specific and 
sensitive in the acute phase of the disease. However, the test is 
reported to detect only about 70% of clinically infected animals and 
seem not to detect asymptomatic animals in the early stage of 
infection (Nicolas et al., 1996).  
 Although it is specific, CFT lacks sensitivity with a positive 
reaction result being only at 1/10 or higher. CFT is also far from robust, 
in a thorough examination of CFT in which over 33000 sera from 
healthy herds were tested between 1991-1994 in Italy. Bellini et al. 
(1998) reported that CFT was 98% specific. Regarding sensitivity, 
based on nearly 600 cattle with specific lesion from 11 infected herds, 
only 64% of animals were positive. Isolation of the causative agent 
from the affected animals was even more insensitive at 54%.  
 Surprisingly, during the Italian outbreaks, abattoir surveillance 
detected nearly as many cases as serological monitoring, while clinical 
examination was much less useful (Regalla et al., 1996). It followed 
that by using CFT as a screening test, some CBPP affected cattle, in 
the early or later stages of infection were missed, accounting for the 
persistence of the disease in Portugal.  
1.8.6.2 Enzyme linked immunosorbent assay (ELISA) 
 The ELISA was used to detect antibodies against M. mycoides 
(Onoviran and Tayler Robenson, 1971). The test was found more 
sensitive than the CFT, slide agglutination serum test and agar gel 
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immunodiffusion test. It could detect M. mycoides antibodies in sera 
of cattle at least 19 months of infection and 25 months after 
vaccination.  
A competitive ELISA (C-ELISA) was developed at CIRAD-
EMVT, Montpellier. The test may have advantages interim of ease of 
testing and standardization of results, but it has sensitivity levels 
similar to that of CFT and thus will enable the persistence of disease 
as seen with CFT (Le Goff and Thiaucourt, 1998).  
1.8.6.3 Immunoblotting tests (IBT) 
 Immunoblotting test is used generally to compare between 
isolated Mmm SC strains. Gonclaves et al. (1998) used it to detect five 
different antigens (110, 98, 95, 62/60 and 45 KDa). These antigens 
were highly characteristic of sera from Portuguese herds affected by 
CBPP (170 cattle).  
There was 79% agreement between CFT and IBT. In a study of 
88 cattle with CBPP lesions, IBT detected 80 positive animals and 
CFT detected 72 (Ayling et al., 1991). Abdo et al. (1998; 2000) 
identified a 48 KDa protein, named LPPQ. It was found in the type 
strain and European, African and Australian field strains. They used 
the protein in an immunoblotting test for the sero-detection of      
Mmm SC in experimentally infected cattle.  
1.8.6.4 Slide agglutination test 
The slide agglutination test using serum (Pricestly, 1951) or 
blood (Newing and Field, 1953) is sensitive in early stages of the 
disease and suitable for establishing of preliminary diagnosis when 
large number of cattle are involved and for selection. So it is 
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recommended to be used as a herd test rather than an individual 
animal.  
The most important test for detecting animals particularly those 
with sequestra is CFT (Campbell and Turner, 1937; Lindley, 1960; 
Huddart, 1963 and Pearson and Mcpherson, 1966). The advantage of 
CFT is the low number of false positive and negative reaction 
(Hudson, 1971). The main disadvantage of CFT is that it fails to detect 
infected animals in the incubation period of the disease.  
1.8.7 Molecular diagnosis 
A powerful diagnostic system based on PCR has been 
developed for rapid detection, identification and differentiation 
between members of the M. mycoides cluster. An arbitrarily primed 
PCR (AP-PCR) of Mmm SC, with Mlip 1 and Mlip 4 primers 
produced a fingerprint with little genomic polymorphism and thus of 
limited epidemiological use. Two bands of 900 bp and 100 bp for 
strains PGI, PO, KH3J and Fatick were produced, although the later 
had a faint band at 400 bp, in contrast to the five M. caprivolum 
strains tested which produced four different patterns (Rawadi et al., 
1995). These test strains were designed from sequences of unknown 
functions or from known genes (Bashiraddin et al., 1994b; Dedieu     
et al., 1994; Hotziel et al., 1996; Niserez et al., 1997; Rodriguez et al., 
1997; Person et al., 1999). With many of these tests, confirmation of 
the presence of Mmm SC-type or production of the expected 
amplification product was possible by the digestion of the product 
with specific restriction enzyme. In some cases the standard detection 
of PCR products by agarose gel electrophoresis was replaced with 
enhanced methods which improved the sensitivity. 
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These methods have been used for the identification and 
detection of Mmm SC-type from culture and clinical materials 
including nasal swab, mucous, pleural fluid, lung tissues, lymph 
nodes, kidneys, spleen and semen from cattle (Bashiruddin et al., 
1994a, 1994b; Nicholas and Palmer, 1994; Bashiruddin et al., 1999a; 
1999b; Stradaioli et al., 1999) and from milk and respiratory tract of 
small ruminants (Brandao, 1995). In some cases they had superior 
diagnostic sensitivities compared with conventional diagnostic tests. 
In particular, the sensitive nested PCR system has been used for the 
detection of Mmm SC from culture and clinical material where the 
target organism may be in low numbers such as in nasal swab samples 
(Hotzel et al., 1996; Niserez et al., 1997).  
1.9 Disease control and eradication 
Control of CBPP can be based on: 
1.9.1 Stamping out policy: 
 This policy is a general method when infection is detected 
early. In the Sudan in which the mode of animal husbandry is nomadic 
this can not be done but cattle owner are persuaded to kill their 
clinically sick animals (Abdalla, 1975), so when the disease is 
reported in the herd its movement is restricted and segregated in 
grazing and watering areas.  
1.9.2 Treatment 
 Another method of control is chemotherapy with broad 
spectrum antibiotics. This is only recommended for control of severe 
local reaction at the vaccination site since its use on actual case of 
CBPP could lead to a high incidence of carrier animals with squestra 
in their lungs. In 1967 the FAO/OIE OAU panel unanimously 
opposed therapeutic treatment for the actual case of CBPP and 
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strongly recommended that mass drug or antibiotic treatment of CBPP 
to be discouraged (FAO Report, 1967).  
1.9.3 Vaccination  
 Vaccination against CBPP in Sudan has been practiced since 
1914 (Anon 1914). In those early days infected pleural exudates from 
a sick animal was inserted under the skin of the tail tip. This method 
usually caused severe swellings.  
 Broth culture vaccine prepared from field strain of M. mycoides 
subsp mycoides was produced in the Veterinary laboratory in 
Khartoum in 1925 (Anon 1925) and in 1926 (Anon 1926). F strain 
isolated in 1944 from pulmonary exudates of naturally infected case 
and was subcultured in glycerine broth (Anon, 1950) was used for 
vaccine production in the Sudan and the recommended dose was 1 ml 
(Abdalla, 1975).  
 T1 strain broth culture vaccine production originated in East 
Africa and was tested in the laboratory and the field in Sudan (Lindley 
and Abdalla, 1967). Comparative studies showed that this vaccine has 
superior immunizing power over F strain (Lindley and Abdalla, 1967, 
Daleel and Lindley, 1970). Cattle vaccinated with this vaccine were 
immune for more than 12 months (Daleel, and Lindley, 1970).  
 The other alternative and most practical way is the use of 
lyophilized vaccine. The research for the production of a dried vaccine 
started in the mid fifties (Gray and Turner, 1954).  Lindley (1971) 
emphasized that the T1 lyophilized vaccine is most valuable tool 
which can be used for controlling of CBPP, being more stable than 
broth culture vaccine (Brown et al., 1965). Later Shallali et al. (1997) 
has successfully prepared lyophilized T1/44 vaccine and has been used 
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in the field since that time. T1/44 /SR strain is streptomycin resistant 
and dependant strain (Anon, 1988). Vaccine made from this strain is 
safe and gives satisfactory immunity for about 14 month (Provost, 
1988).  
1.10 Suitable age of vaccination 
 Colostrums is the source of antibodies which pass from calf gut 
to its blood stream and persist for up to 60 day (Stone, 1969). On the 
other hand Turner and Trethewie (1961) found that calves born to 
unvaccinated dams were highly susceptible to joint involvement 
within the first week of life. It was found that calves born to recently 
vaccinated dams showed antibodies one week post-parturition. Titers 
reached maximum at one month and then gradually declined. By the 
six months, 71% of the tested calves sera were found negative. On the 
basis of these results it is suggested that six months is the suitable age 
to start vaccination of calves from recently vaccinated dams (Shallali 
et al., 1998).  
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CHAPTER TWO 
MATERIALS AND METHODS 
2.1 Sterilization 
 All glassware used were soaked for an hour in warm 10% 
detergent solution, scrubbed and rinsed in running warm water. The 
glassware were then rinsed in distilled water and were put on clean 
surface to drain dry. Graduated and capillary pipettes, Petri dishes, 
forceps, scissors, glass syringes, needles and cotton swabs were 
sterilized in hot air oven at 160ºC for 2 h. Vials such as bijou, 
universal, and Seitz-filter were sterilized by autoclaving at 121ºC 
(15Ib/inch2) for 15 minutes.  
2.1.1 Collection of the samples 
 Lung tissue samples were collected from different 
slaughterhouses (Ganawa, Al Sabaloga, Alkadaro, El Huda) in 
Khartoum State between January – May 2008. A total of 790 animals 
were investigated and only 55 lungs showed pneumonic lesions  
(Table 3).  
 Pneumonic lung tissues and sera were also collected from 6 
animals showing typical clinical signs and post-mortem lesions of 
CBPP at one of Alkadaro Dairy Farms, Khartoum North.  
 A total of 200 serum samples were collected randomly from 
dairy farms and cattle herds in Khartoum State (Table 4).  
2.1.2 Method of collection of samples  
 Specimens (5 cm3) were cut and placed in sterile plastic bags, 
labeled and transported in ice box at to the Central Veterinary 
Research Laboratory, Soba. 
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Table 3: Sources of lung tissue samples collected from different 
slaughterhouses in Khartoum State.  
 
Slaughter 
house 
No. of 
animals 
examined 
No. of  
Pneumonic   
lungs 
Alkadaro  240 15 
Al Huda  100 15 
Alsbaloga  150 15 
Ganawa  300 10 
Total  790 55 
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Table 4: Distribution of bovine serum samples according to localities  
Source of samples No. of sample collected 
Alkadaro  40 
Soba  80 
Hilat Kuku  15 
Kafori  25 
Omdurman  20 
Shambat  15 
Different samples  5 
Total 200 
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For collection of serum, 10 ml of blood samples were collected 
in sterile plain vacutainers. Samples were left for 1h at room 
temperature then kept overnight in refrigerator at 4ºC. Samples were 
then centrifuged at 3000 rpm for 10 min. The separated serum was 
aspirated with sterile pipette, transferred into sterile containers and 
stored at -20ºC till used.  
2.2 Medium 
 A basic medium of beef heart infusion (Oxoid) supplemented 
with yeast extract (fresh and powder), horse serum, glucose, in 
addition to penicillin and thallium acetate was used in the study. The 
medium was used as broth or solid medium.   
2.2.1 Fresh yeast extract stock solution 
 Two hundred and fifty grams of pure baker’s dry yeast were 
added to 1L of distilled water, heated to boiling with stirring for 30 
min. The mixture was centrifuged at 6000 rpm for 10 min, then 
sterilized by filtration through 0.2 um pore size filter (Seitz-filter). The 
filterate was distributed into 100 ml volume and stored at -20ºC until 
used.  
2.2.2 Yeast extract stock solution 
 Twenty five grams of yeast extract powder (Oxoid) were added 
to 100 ml distilled water and dissolved using magnetic stirrer. The 
preparation was sterilized by filtration through 0.2 um pore size filter 
(Seitz- filter). The filtrate was distributed in 20 ml quantities into 
sterile universal bottle, stored at -20ºC and used within one year.  
2.2.3 Penicillin stock solution  
 One million IU Benzyl Penicillin (Alembic) was dissolved in 20 
ml sterile distilled water, stored at (-) 20ºC and used within one year.  
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2.2.4 Thallium acetate stock solution  
 Thallium acetate 10% was prepared and sterilized by 
autoclaving at 121ºC for 15 min. The sterilized solution was stored at 
4ºC and used within one year.  
2.2.5 Glucose solution 
 Fifty grams of glucose were dissolved in 100 ml distilled water 
and sterilized by autoclaving at 110ºC for 5 min. The sterilized 
solution was stored at 4ºC.  
2.2.6 Preparation of horse serum 
 Blood was collected aseptically from the jugular vein of a 
healthy horse into bottles contained 20% trisodium citrate. It was kept 
on the bench overnight. The plasma was then separated and measured. 
To each 100 ml plasma, one ml CaCl2 was added. The mixture was 
shaken until fibrin was separated, then the serum was put in water-
bath at 50ºC for half an hour to inactivate the complement and then 
sterilized by filtration through 0.2 µm pore size filter (size-filter). 
Aliquots of 50 and 100 ml serum were prepared and stored at 4ºC 
until used.  
2.2.7 Liquid medium  
Heart infusion broth:  
  PART A: Heart infusion broth-base (Oxoid):  
  Heart infusion broth   40 g 
  Tryptose     10 g 
  Sodium chloride    5 g 
  Distilled water    880 ml  
   pH was adjusted to 7.8 
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PART B:  
  Horse serum    100 ml  
  Fresh yeast extract   20 ml  
  Glucose     2 ml  
  Penicillin     0.33 ml  
Thallium acetate    0.25 ml  
Solid ingredients in part A were dissolved by boiling and the 
pH was adjusted to 7.8. Part A was then sterilized by autoclaving at 
121ºC for 15 min. After cooling part B was added aseptically and the 
mixture was distributed in 5 ml amounts into sterile test tubes. The 
distributed medium was incubated at 37ºC overnight to check sterility 
and then stored at 4ºC till used.  
2.2.8 Solid medium 
Heart infusion agar:  
Part A: Heart infusion agar-base (Oxoid):  
  Heart infusion agar   50g  
 Tryptose     10g  
 Sodium chloride    5g  
 Distilled water    880 ml  
  pH was adjusted to 7.8 
Part B:  
 Horse serum    100 ml 
 Yeast extract 30%   20 ml  
 Glucose 100.000 IU  0.00 ml  
Thallium acetate 10%  0.25 ml  
Solid ingredients in part A were dissolved by boiling and the 
pH was adjusted to 7.8. Part A was then sterilized by autoclaving at 
121ºC for 15 min. After cooling to 45-50ºC, part B (pre-incubated at 
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45ºC) was then added aseptically to part A. The mixture was 
distributed immediately in 15 ml amounts into sterile Petri dishes and 
allowed to solidify on leveled surface.  
2.3 Method of isolation  
 Lung tissue samples were pulverized in broth medium with 
antibiotics. The suspension was then diluted through tenfold steps (to   
10-3) to minimize bacteria contamination. Dilutions were plated on 
solid medium. The pleural fluid was inoculated directly without 
previous dilution onto solid medium.   
2.3.1 Incubation  
 The inoculated broth cultures were incubated at 37ºC 
aerobically for three to ten days. The inoculated solid medium was 
incubated aerobically at 37ºC in a humid chamber for 3 to 15 days. 
Further incubation for up to 21 days was continued if no visible 
growth was seen.  
2.3.2 Detection of growth 
 The inoculated liquid medium was examined daily. Tubes 
showing faint turbidity (compared with the control medium) after day 
3 of incubation were subjected to further investigation by dark field 
microscopy for presence of filamentous microorganism or bacterial 
contamination.  
2.3.3 Purification and storage of isolate  
 Broth cultures were streaked on solid medium. The plates were 
then incubated as mentioned before. The surface of solid medium was 
examined under (x40) power lens of stereomicroscope for fried-egg 
type colony. When a fried egg appearance colony appeared after 3 
days, agar cube containing single colony was incised and used to 
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inoculate broth medium. After aerobic incubation at 37ºC and when 
faint turbidity appeared, the culture was then inoculated on solid 
media without inhibitors to exclude the L-form bacteria. Fried-egg 
types of colonies were then used to inoculate broth media. When 
inoculated medium showed growth, the culture was stored at -20ºC.  
2.4 Identification of the isolates 
2.4.1 Microscopy  
 Broth cultures showing signs of growth were investigated by 
dark filed microscopy. A drop of culture was put on clean slide and 
covered with a cover slip. The slide was then examined under oil 
emersion lens. Short or long filaments indicated the presence of 
Mycoplasma.  
2.4.2 Cultural characteristics  
 Growth of the isolate into liquid medium and on solid medium 
and the growth conditions were fully described.  
2.4.3 Biochemical tests 
2.4.3.1 Digitonin test:  
  Seventy five mg of digitonin were added to 5 ml ethanol 95% in 
a screw-capped tube and the solution was heated gently in flask of 
boiling water to dissolve the digitonin completely. Several sterile filter 
paper disks approximately 6 mm in diameter were placed in sterile 
plastic Petri dish and 0.025 ml of digitonin solution were added to 
each disk. The disks were dried overnight at 37oC and stored at 4oC 
until use.   
2.4.3.1.1 Method of digitonin test 
A solid medium was inoculated by the drop technique. A drop 
of culture was placed on the surface of medium and allowed to run in 
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one way. Then a disk of digitonin was placed aseptically on the line of 
culture. After aerobic incubation at 37ºC for 3-10 days, inhibition of 
growth only around the disk indicated the sensitivity of the isolate to 
digitonin.  
2.4.4 Serological test 
2.4.4.1 Growth inhibition test 
 Growth inhibition test (GIT) was used for the identification of 
isolates and was performed as described by Wallace and Clyde 
(1983).  
2.4.4.1.1 Materials  
 Sterile paper disks (6-7 mm in diameter) were impregnated with 
antisera against Mmm (SC). The antisera were obtained from Central 
Veterinary Research Laboratory, Soba, Sudan.  
- Broth cultures of isolates, 3 days old.  
- Heart infusion agar plates.  
- Hundred ml – volume automatic pipettes and sterile tips.  
- Sterile forceps.  
- Ethanol 95%. 
2.4.4.1.2 Method of growth inhibition test  
Agar plates were dried in the incubator at 37 ºC for 30 min. 
Then 0.1 ml of the broth culture was deposited on the agar surface and 
allowed to run across the plate. The plate was left at room temperature 
until the entire inoculum was absorbed into the medium. The sterile 
disk (containing Mmm SC-type antisera) was then placed carefully on 
the path of the drop using alcohol flamed forceps. The plate was 
incubated aerobically in a humid chambers at 37ºC for 3-5 days. The 
surface of the plate was then examined using stereomicroscope at low 
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magnification for evidence of a zone without colonies encircling the 
disk i.e. zone of growth inhibition. The result was recorded by 
measuring the width of the zone of inhibition from the edge of the 
paper disk to the nearest colonies. 
2.4.4.2 Competitive ELISA 
 Serum samples were tested using competitive ELISA. All 
samples as well as controls were tested by ELISA in duplicates 
(Avrameas et al., 1978, Engvall and Perlmann, 1972).  
2.4.4.2.1 Principle of the test 
 It is an assay to determine the presence of anti-CBPP antibody 
in serum. It is based on the competition between the anti-CBPP 
monoclonal antibody and the antibodies in the serum sample binding 
to the CBPP antigen. The presence of antibodies CBPP in the serum 
sample will block reactivity of the monoclonal antibody resulting in 
reduction in expected colour following the addition of conjugate and 
substrate chromogen solution. As this is a solid phase assay, wash step 
are required between each step to ensure removal of unbounded 
reagents.  
Competitive ELISA kit was that of CIRDO/Institut 
POURQUIER, CBPP serum competition ELISA- Version 
PO5410/01- Page 1/6. The technique described sheet fact 
accompanied the kit was followed.   
2.4.4.2.2 The components of the kit 
- Monowell coated microplates.  
- Wash concentrate (20x). 
- Dilution buffer 24. 
- Control sera. 
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- Monoclonal antibody 117/5 (anti- Mmm SC) (Mab).  
- Monoclonal anti-mouse 1gG peroxides conjugate.  
- Revelation solution 3 (TMB). 
- Stop solution (H2SO4 O.5M solution).    
2.4.4.2.3 Instruments 
- ELISA plates.  
- Microplates covers (lid, aluminium foil).  
- Adjustable micropipettes with different volumes and tips.  
- An incubator with shaker.  
- ELISA reader with computer.  
- Disposable Petri dishes.  
2.4.4.2.4 Test procedure 
 The test was carried out according to manufacture instructions 
as follows:  
1- Deposit of the sera  
 The samples were diluted and incubated with the monoclonal 
anti-Mmm SC antibody (Mab) in pre-dilution plate.  
a) Dilution of the sera  
- Hundred µl of dilution buffer 24 were dispensed in all wells of 
Pre-Plate.  
- Eleven µl of the 3 control samples CP++ were dispensed in B1, 
B2, C1, C2 and CP+ in D1, D2, E1, E2 and CN in H1, H2.  
- Eleven µl of dilution buffer 24 were dispensed in the wells A1, 
A2.  
- Eleven µl of the samples in the other wells (A3 to H12). 
According to the plate layout (Figure 1).  
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 1 2 3 4 5 6 7 8 9 10 11 12 
A Cc Cc 1          
B CP++ CP++ 11          
C CP++ CP++ 21          
D CP+ CP+ 31          
E CP+ CP+ 41          
F Cm Cm 51          
G Cm Cm 61          
H CN CN 71          
Figure 1: Distribution of sera and monoclonal antibody in the 
microplate in competitive ELISA  
Cc:  Conjugate control (without serum, without Mab = 100% inhibition).  
Cm:  Monoclonal control (without serum = 0% inhibition). 
CP++:  Strong positive serum. 
CP+:  Weak positive serum.  
CN:  Negative serum. 
1:  Sample no 1 
2:  Sample no 2 
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b) Reconstitution and deposit of the monoclonal antibody (Mab) 
- The Mab was reconstituted with 1mL of distilled water.  
- The Mab was diluted to 1/20 in dilution buffer 24.  
- One hundred and ten µl diluted Mab was dispensed in all wells 
except A1 and A2.  
C) Incubation of the mixture serum/ monoclonal antibody 
- Hundred µl of the mixture sample / Mab were transferred from 
pre-plate to the coated plate.  
- The plate was covered and incubated at 37oC on shaker for 1 h.  
2- Washing:  
- The wash concentrate 20x was diluted in 1900 ml distilled 
water and this solution called wash solution.  
- The plate was washed 3 times with wash solution and dried.  
3- Deposit of the conjugate:  
- The conjugate was diluted to 1/100 in dilution buffer 24.  
- Hundred µl of the diluted conjugate were dispensed in all wells.  
- The plate was covered and incubated at 37oC on shaker for 30 ± 
3 min.  
4- Washing  
 The plate was washed 3 times with wash solution and dried.  
5- Revelation  
- Hundred µl of the revelation solution 3 were dispensed in all 
wells.  
- The plate was incubated for 30 min at 37oC in the dark. 
- The reaction was stopped by addition of 100 µl stop solution to 
all wells.  
Finally the plate was read at 450 nm.  
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The reader was connected to a computer loaded with ELISA 
Data Interchange (EDI) software, which was used to automate the 
reading and calculation of percentage of inhibition (PI) values. The 
optical density (OD) values were converted to percentage inhibition 
by using the following formula:  
P1 = 100x [(optical density of monochnal control – optical density of 
the test) / (optical density of monoclonal control – optical density of 
the conjugate control)].  
P1 = 100 x [(ODcm – OD test) / (ODcm- ODCc)] 
Sera showing P1 equal to or lower than 40% were considered negative 
and those showing P1 equal or greater than 50% were considered 
positive.  
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CHAPTER THREE 
RESULTS 
 
3.1 Isolation of Mycoplasma mycoides subsp. mycoides small 
colonies  
 A total of 55 pneumonic lung samples were collected from 
different slaughterhouses in Khartoum State. Six samples were also 
collected from six animals showing clinical signs and post-mortem 
lesions of CBPP at Alkadaro. Post-mortem examination of the six 
clinical cases revealed restriction of lesions to thoracic cavity. Lesions 
included adhesions of the lungs to the chest cavity, lungs were 
covered with yellowish materials, increase of pleural fluid and 
marbling appearance.  
 No isolate was obtained from 55 pneumonic lungs collected 
from slaughter houses. However two isolates were obtained from the 
six lung samples collected from Alkadaro. 
3.2 Identification of the isolates 
3.2.1 Dark field microscopy 
 When smears prepared from cultures were examined under oil 
immersion lens of dark field microscope short and long filaments were 
seen only in case of the two samples for which the two isolates were 
obtained.  
3.2.2 Cultural characteristics  
 The inoculated Petri dishes when examined by steromicroscope 
at low magnification after 8 days of incubation at 37oC, revealed fried 
egg appearance (Figure 2) in only two plates which were cultured by 
the two of the six clinical samples.  
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3.2.3 Digitonin test  
 An inhibition zone of 10 mm around digtonin disk was noticed 
in case of the two isolates from two of the clinical cases.  
3.2.4 Growth inhibition test 
 The growth of the two isolates was inhibited by Mmm Sc 
antisera and inhibition zone around Mmm SC antisera disk was seen. 
The two isolates from infected cases in Alkadaro were 
characterized and identified as Mycoplasma mycoides subsp mycoides 
(SC. Type) depending on dark – field microscopy, cultural 
characteristics, digitonion test and growth inhibition.  
3.2.5 Serological identification 
3.2.5.1 Competitive ELISA  
 Two hundred serum samples collected in this study were tested 
for presence of antibodies against Mmm SC with C-ELISA. 
Antibodies were detected in 114 (57%) serum samples (Table 5).  
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Table (5): Detection of antibodies of Mycoplasma mycoides subsp 
mycoides small colony type of bovine sera by competitive 
ELISA  
Source of samples Positive samples 
Sero positive 
percent (%) 
Alkadaro  25 62.5 
Soba  45 56.3 
Hilat Kuku  10 66.7 
Kafori  16 64.0 
Omdurman  9 45.0 
Shambat  4 26.7 
Different samples  5 100.0 
Total 114 57.0 
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Fig. (2): Colonial morphology of Mycoplasma mycoides subsp. 
mycoides small colony type isolate grown on heart infusion 
agar after 8 days incubation (x 40) 
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CHAPTER FOUR 
DISCUSSION 
 
Sudan is a big country in Africa, approximately one million 
square miles in area. It shares borders with nine countries in central 
and east Africa. It has the largest and most species diverse livestock 
population in Africa that contribute greatly to the national economy.  
Efforts have been made and continue to be made in the control 
of animal diseases in the country. This has been done usually by using 
therapeutics and vaccines. Some constrains facing this policy 
summarized as follows: continuous movement of animals, husbandry 
adopted in Sudan, availability of vaccines, lack of rapid and accurate 
diagnosis and treatment and instability due to war in the western 
region. 
Contagious bovine pleuropeumonia (CBPP) is considered as 
one of the most important animal diseases in Africa including Sudan 
after the eradication of rinderpest. The disease causes economic losses 
among cattle in the form of debilitation and death of infected animals. 
The Government of Sudan paid attention to this disease due to its 
direct effects on milk and meat production and therefore, the food 
intake of poor people. It also affects the external trade of livestock. 
CBPP vaccine production in Sudan started early in 1925 using a local 
strain. In 1970, T144 was introduced in the form of broth culture 
vaccine and in 1999; a lyophilized form of this vaccine was produced. 
It is important to note that the quantity of this vaccine which produced 
in the country, was not sufficient to vaccinate cattle in Sudan. For this 
and other reasons, cattle owners used antibiotics to treat their animals 
infected with CBPP. In chronic cases, there will be consolibation of 
the lung and the septa with presence of sequestra. This sequestra 
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contains viable mycoplasma which may not be affected by antibiotics 
and breakdown of the sequestra capsules in chronically affected and 
recovered animals is a major factor in spread and persistence of CBPP 
in endemic areas.  
In this study samples were collected from different 
slaughterhouses in Khartoum State revealed two isolation of 
Mycoplasma mycoides subsp. mycoides Sc type. The isolation was 
performed on beef heart infusion medium. The infected animals 
showed typical postmortem findings of CBPP. The isolates were 
identified as Mmm SC based on microscopic appearance, cultural 
characteristics, digitonin sensitivity and serological identification with 
GIT. This isolation confirms the presence of the disease and this 
agrees with many investigators surveyed the prevalence of CBPP 
(Ameera, 2002; Karam, 2005). They reported the presence of the 
disease in Khartoum state. Reports of the Administration of Animal 
Health and Epizootic Control and Ministry of Animal Resources 
(2003) stated that sporadic cases of CBPP were observed in certain 
areas of Khartoum State including Khartoum North.  
Identification of the isolates was based mainly on serological 
identification with growth inhibition test. The test recommended by 
the OIE (1991). It is simple, specific, false negative and false positive 
results are rare. The isolates revealed a small inhibition zone around 
the disk and that can be attributed to many factors. Wallace and Clyde 
(1983) reported that the inhibition effect does not consist always of 
sharply defined zone surrounding antiserum disks. Strain variation and 
antiserum quality in addition to inoculum size and titer, may produce 
zones of suppressed (breakthrough colonies) rather complete zone of 
inhibition around the disks. Generally, any clear-cut suppression of 
growth can be considered as a positive result, assuming that antisera 
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are known to be mono specific and do not possess nonspecific 
inhibition properties.  
Serum samples collected from 2 cases from which the isolates 
obtained were examined by C-ELISA and showed presence of Mmm 
Sc-type.  
One hundred and fourteen out of 200 serum samples collected 
randomly from cattle in different areas of Khartoum State gave 
positive result with competitive ELISA. Higher antibody titers were 
detected in sera from Hilat Kuku while low titres were detected in sera 
from Shambat.  
The OIE reference method for CBPP serology is the 
complement fixation test (CFT). This technique was used in the past 
for CBPP eradication in many countries. However, it presents some 
disadvantages, mainly the difficulties of antigen production, 
standardization and the existence of non-specific positive results. For 
these reasons the CIRD-EMTV (FAO World Reference Center for 
CBPP) has developed a second test, a competitive ELISA based on a 
monoclonal anti- Mmm SC antibody named 117. This test is an 
alternative to CFT for the OIE and can be used for the official CBPP 
controls. For both ELISA and CFT, the disease in the incubation stage 
cannot be detected.  
CFT or C-ELISA can be use to evaluate efficient control of 
vaccination. However, as the post vaccination antibodies do not 
persist more than 3 months, CFT or C-ELISA can be used for 
detection of natural infection, even in areas where vaccination is used 
(Ayling et al., 1999).  
Results of this study are clear confirmation that CBPP is 
persistent in Khartoum State and prompt action is needed to find out 
all infected focal areas and is find a control measure.  
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CONCLUSION AND RECOMMENDATIONS 
 
 
Conclusions 
- Mycoplasma mycoides subs mycoides SC was isolated from 
infected lungs.  
- C-ELISA detected the presence of Mmm SC antibodies in 57% 
of cattle examined. 
 
Recommendations 
- More isolates of Mycoplasma mycoides subsp. mycoides should 
be isolated to help in epidemiological studies and control 
programmes of CBPP. 
- Extensive and intensive vaccination should be carried out in all 
endemic areas.  
- Further investigation have to be done to examine the possibility 
of use gene detection method for diagnosis of CBPP in Sudan. 
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